397 related articles for article (PubMed ID: 12782048)
1. Recent advances in veterinary vaccine adjuvants.
Singh M; O'Hagan DT
Int J Parasitol; 2003 May; 33(5-6):469-78. PubMed ID: 12782048
[TBL] [Abstract][Full Text] [Related]
2. Recent developments in adjuvants for vaccines against infectious diseases.
O'Hagan DT; MacKichan ML; Singh M
Biomol Eng; 2001 Oct; 18(3):69-85. PubMed ID: 11566599
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in vaccine adjuvants.
Singh M; O'Hagan DT
Pharm Res; 2002 Jun; 19(6):715-28. PubMed ID: 12134940
[TBL] [Abstract][Full Text] [Related]
4. Recent developments in vaccine delivery systems.
O'Hagan DT
Curr Drug Targets Infect Disord; 2001 Nov; 1(3):273-86. PubMed ID: 12455401
[TBL] [Abstract][Full Text] [Related]
5. Advances in vaccine adjuvants for infectious diseases.
Singh M; Srivastava I
Curr HIV Res; 2003 Jul; 1(3):309-20. PubMed ID: 15046255
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvants--essential components of new generation vaccines].
Dzierzbicka K; Kołodziejczyk AM
Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510
[TBL] [Abstract][Full Text] [Related]
7. Microparticles as vaccine adjuvants and delivery systems.
O'Hagan DT; Singh M
Expert Rev Vaccines; 2003 Apr; 2(2):269-83. PubMed ID: 12899577
[TBL] [Abstract][Full Text] [Related]
8. Adjuvants in veterinary vaccines: modes of action and adverse effects.
Spickler AR; Roth JA
J Vet Intern Med; 2003; 17(3):273-81. PubMed ID: 12774966
[TBL] [Abstract][Full Text] [Related]
9. Adjuvants and delivery systems in veterinary vaccinology: current state and future developments.
Heegaard PM; Dedieu L; Johnson N; Le Potier MF; Mockey M; Mutinelli F; Vahlenkamp T; Vascellari M; Sørensen NS
Arch Virol; 2011 Feb; 156(2):183-202. PubMed ID: 21170730
[TBL] [Abstract][Full Text] [Related]
10. Selection of adjuvants for vaccines targeting specific pathogens.
Sarkar I; Garg R; van Drunen Littel-van den Hurk S
Expert Rev Vaccines; 2019 May; 18(5):505-521. PubMed ID: 31009255
[TBL] [Abstract][Full Text] [Related]
11. Adjuvants for veterinary vaccines--types and modes of action.
Gerdts V
Berl Munch Tierarztl Wochenschr; 2015; 128(11-12):456-63. PubMed ID: 26697712
[TBL] [Abstract][Full Text] [Related]
12. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
13. Targeting the innate immune response with improved vaccine adjuvants.
Pashine A; Valiante NM; Ulmer JB
Nat Med; 2005 Apr; 11(4 Suppl):S63-8. PubMed ID: 15812492
[TBL] [Abstract][Full Text] [Related]
14. Recent developments in leishmaniasis vaccine delivery systems.
Bhowmick S; Ali N
Expert Opin Drug Deliv; 2008 Jul; 5(7):789-803. PubMed ID: 18590463
[TBL] [Abstract][Full Text] [Related]
15. Immunological adjuvants and their modes of action.
Allison AC
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):141-7. PubMed ID: 9597079
[TBL] [Abstract][Full Text] [Related]
16. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.
Nordly P; Madsen HB; Nielsen HM; Foged C
Expert Opin Drug Deliv; 2009 Jul; 6(7):657-72. PubMed ID: 19538037
[TBL] [Abstract][Full Text] [Related]
17. Adjuvants for Animal Vaccines.
Burakova Y; Madera R; McVey S; Schlup JR; Shi J
Viral Immunol; 2018; 31(1):11-22. PubMed ID: 28618246
[TBL] [Abstract][Full Text] [Related]
18. Mucosal delivery of vaccines in domestic animals.
Gerdts V; Mutwiri GK; Tikoo SK; Babiuk LA
Vet Res; 2006; 37(3):487-510. PubMed ID: 16611560
[TBL] [Abstract][Full Text] [Related]
19. Particulate delivery systems for animal vaccines.
Scheerlinck JP; Greenwood DL
Methods; 2006 Sep; 40(1):118-24. PubMed ID: 16997719
[TBL] [Abstract][Full Text] [Related]
20. Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems.
Foged C
Ther Deliv; 2011 Aug; 2(8):1057-77. PubMed ID: 22826868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
